FDA
approval
· 2021-04-28
FDA Approved: NABUMETONE — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA approved a supplemental application for Nabumetone submitted by Actavis Pharma, Inc., relating to Nabumetone's approval status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NABUMETONE (NABUMETONE)